Patent Yard Sign in
Expired Australian patentAustralia

213-benzothiaoxadiazole derivatives having endothelin receptor-antagonistic action

AU 1997018757 · Applicant: Merck Patent Gesellschaft Mit Beschrankter Haftung

AusPat record

Overview

Drawings and full text

Its specification, documents and status are on IP Australia's AusPat.

Open the AusPat record

Read the whole patent

Listed from its IP Australia record in Patent Yard's archive of Australian patents past their term. Its claims, description and drawings are in the AusPat record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed February 20, 1997 and granted October 12, 2000. An Australian standard patent lasts 20 years from its date of patent, which is at most a year after this filing, so its term ended by February 20, 2018.
  • A pharmaceutical extension adds at most five years, so even that would have ended by February 20, 2023.
  • We check Australian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledFebruary 20, 1997
GrantedOctober 12, 2000
Term ended byFebruary 20, 2018
Application numberAU 1997018757
Classification (IPC)C07D285/14 +2 more

Timeline

Timeline From IP Australia dates

1998200120042007201020132016Application filedFeb 20, 1997Patent grantedOct 12, 2000Term ended byFeb 20, 2018

Sources & verification

Everything on this page comes from the IP Australia record linked above. Data from IP Australia's IPGOD, licensed under CC BY 2.5 AU.